Molecular mechanisms of hepatic metastasis in colorectal cancer

被引:80
作者
Rudmik, LR
Magliocco, AM
机构
[1] Univ Calgary, Dept Surg, Calgary, AB, Canada
[2] Univ Calgary, Dept Oncol, Calgary, AB, Canada
关键词
D O I
10.1002/jso.20393
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Colorectal cancer currently accounts for 11% of all cancers in the United States and is the second leading cause of cancer-related death, with the majority of deaths attributable to hepatic metastases. Many new studies are elucidating the complex molecular factors involved in this event, which could be used to generate clinically applicable screening and therapeutic tools. Methods: An initial Pubmed and Medline literature search using keywords such as, molecular factor, colorectal cancer, hepatic metastasis/es, and main headings, such as angiogenesis, was reviewed. Since there are many molecular factors involved in this process not all could be included in this review. The list of discussed gene products was limited to the most studied factors, identified by the number of references in the literature search, and additional recently discovered gene products with in-vivo evidence of strong metastasis association. Results: Twenty molecular factors were identified and included in the discussion of this review article. The molecular factors were separated into four groups based on their function, they are: proteolysis, adhesion, angiogenesis, and cell survival. All factors have a promising role as a screening or therapeutic target. Conclusion: This review has identified the many recent advances in elucidating the pathways involved in colorectal cancer hepatic metastasis. By better understanding the many complex molecular events involved in metastasis, novel screening and therapeutic tools may be developed with the ultimate goal of preventing metastasis and increasing patient survival.
引用
收藏
页码:347 / 359
页数:13
相关论文
共 125 条
[1]   Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers [J].
Adachi, Y ;
Yamamoto, H ;
Itoh, F ;
Hinoda, Y ;
Okada, Y ;
Imai, K .
GUT, 1999, 45 (02) :252-258
[2]   Osteopontin identified as colon cancer tumor progression marker [J].
Agrawal, D ;
Chen, T ;
Irby, R ;
Quackenbush, J ;
Chambers, AF ;
Szabo, M ;
Cantor, A ;
Coppola, D ;
Yeatman, TJ .
COMPTES RENDUS BIOLOGIES, 2003, 326 (10-11) :1041-1043
[3]   Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach [J].
Ahmed, N ;
Oliva, K ;
Wang, Y ;
Quinn, M ;
Rice, G .
PROTEOMICS, 2003, 3 (03) :288-298
[4]   Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-β1 integrin complex in colon cancer cells [J].
Ahmed, N ;
Oliva, K ;
Wang, Y ;
Quinn, M ;
Rice, G .
BRITISH JOURNAL OF CANCER, 2003, 89 (02) :374-384
[5]   Transcriptional induction of the urokinase receptor gene by a constitutively active Src - Requirement of an upstream motif (-152/-135) bound with Sp1 [J].
Allgayer, H ;
Wang, H ;
Gallick, GE ;
Crabtree, A ;
Mazar, A ;
Jones, T ;
Kraker, AJ ;
Boyd, DD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18428-18437
[6]   Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer [J].
Amaya, H ;
Tanigawa, N ;
Lu, C ;
Matsumura, M ;
Shimomatsuya, T ;
Horiuchi, T ;
Muraoka, R .
CANCER LETTERS, 1997, 119 (02) :227-235
[7]   Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling [J].
Avizienyte, E ;
Wyke, AW ;
Jones, RJ ;
McLean, GW ;
Westhoff, MA ;
Brunton, VG ;
Frame, MC .
NATURE CELL BIOLOGY, 2002, 4 (08) :632-638
[8]  
Baker EA, 2000, J CLIN PATHOL-MOL PA, V53, P307
[9]   Factors promoting tumor angiogenesis [J].
Beckner, ME .
CANCER INVESTIGATION, 1999, 17 (08) :594-623
[10]   SIGNALS AND RECEPTORS INVOLVED IN RECRUITMENT OF INFLAMMATORY CELLS [J].
BENBARUCH, A ;
MICHIEL, DF ;
OPPENHEIM, JJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11703-11706